Tag: licensing
-
New Adaptive Aircraft Control System Flight Tested
20 March 2015. U.S. Air Force pilots tested a new flight control system designed by engineers at University of Illinois that automatically adapts aircraft to changing conditions faster than most human pilots can respond. The L1 adaptive control system is a product of the university’s Advanced Control Research Laboratory in Urbana, Illinois led by mechanical…
-
Lilly Acquiring Treatment for Autoimmune Disorders
19 March 2015. The pharmaceutical company Eli Lilly and Company is acquiring from Hanmi Pharmaceutical, an experimental drug that blocks the actions of an enzyme associated with rheumatoid arthritis and other autoimmune diseases. The deal can pay Hanmi, in Seoul, Korea, as much as $690 million. Autoimmune disorders are diseases where the body’s immune system…
-
UC-Davis Spins Off Irrigation Technology Start-Up
19 March 2015. A graduate student in agriculture at University of California in Davis turned his research on irrigation technology into a new enterprise addressing the chronic drought conditions facing that state’s farmers. Tom Shapland started Tule Technologies Inc. in January 2014 that licensed his research measuring agricultural water use from the university. Tule (pronounced…
-
MedImmune, Joslin Partner on Diabetes Research
10 March 2015. Joslin Diabetes Center in Boston and MedImmune, the biotechnology subsidiary of pharmaceutical company AstraZeneca, are collaborating on research to identify new drugs to treat diabetes. While the partnership calls for MedImmune to fund research conducted at Joslin, financial terms of the deal were not disclosed. Diabetes is a chronic condition where the pancreas…
-
Alliance to Build Photonic Mosquito Control Device
3 March 2015. A collaboration between a social enterprise and lighting technology company aims to develop a laser device to control disease-carrying mosquitoes without pesticides. Financial details of the partnership between Global Good and Lighting Science Group, a designer of advanced industrial and residential lighting systems, were not disclosed. Global Good brings together government, business,…
-
Genzyme Licensing Gene Therapies from Biotech Start-Up
11 February 2015. Voyager Therapeutics, a designer of gene therapies for central nervous system diseases, is licensing some of its treatments now in development to Genzyme Corp., a biotechnology subsidiary of the drug maker Sanofi. The deal is expected to bring the one year-old spin-off from four university research labs as much as $845 million.…
-
Biotech, Hospira to Partner on Biosimilar for Eye Disease
10 February 2015. Pfenex Inc., a biotechnology company in San Diego, is licensing its lead product to treat age-related macular degeneration to biologic therapy maker Hospira. The deal can bring Pfenex as much as $342 million, plus royalties on sales of products from the collaboration, over at least the next five years. Age-related macular degeneration is…
-
Zymeworks, Celgene to Develop Double-Binding Antibodies
21 January 2015. Zymeworks Inc., a biotechnology company in Vancouver, Canada and pharmaceutical maker Celgene Inc. are developing biologic therapies using Zymeworks’ antibody technology. The deal makes Zymeworks eligible for up to $164 million from Celgene for each candidate developed under the partnership, as well as an unspecified initial payment and equity investment. Under the…
-
Neuropore, UCB Partner on Parkinson’s Drugs
16 January 2015. UCB, a biopharmaceutical company in Brussels, is licensing an experimental drug to treat Parkinson’s disease developed by Neuropore Therapies Inc., a biotechnology company in San Diego. The agreement gives UCB a worldwide license for the compound and is expected to pay Neuropore as much as $480 million. Parkinson’s disease occurs when the brain…
-
Roche Buys $1 Billion Stake in Cancer Genetics Company
12 January 2015. Pharmaceutical company Roche is acquiring a majority stake in Foundation Medicine, a company conducting personal genomic analyses for cancer patients. The investment, licensing, and collaboration deal is expected to bring Foundation Medicine, in Cambridge, Massachusetts more than $1 billion. Foundation Medicine — founded by scientists at Dana-Farber Cancer Institute, Harvard Medical School,…